nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapiprazole—ADRA1D—Adrenoceptors—ADRB1—periodontitis	0.112	0.112	CbGpPWpGaD
Dapiprazole—ADRA1B—Adrenoceptors—ADRB1—periodontitis	0.093	0.093	CbGpPWpGaD
Dapiprazole—ADRA1A—Adrenoceptors—ADRB1—periodontitis	0.0826	0.0826	CbGpPWpGaD
Dapiprazole—ADRA1D—Monoamine GPCRs—ADRB1—periodontitis	0.0396	0.0396	CbGpPWpGaD
Dapiprazole—ADRA1D—Amine ligand-binding receptors—ADRB1—periodontitis	0.0333	0.0333	CbGpPWpGaD
Dapiprazole—ADRA1B—Monoamine GPCRs—ADRB1—periodontitis	0.0329	0.0329	CbGpPWpGaD
Dapiprazole—ADRA1A—Endothelin Pathways—ADRB1—periodontitis	0.0292	0.0292	CbGpPWpGaD
Dapiprazole—ADRA1A—Monoamine GPCRs—ADRB1—periodontitis	0.0292	0.0292	CbGpPWpGaD
Dapiprazole—ADRA1B—Amine ligand-binding receptors—ADRB1—periodontitis	0.0276	0.0276	CbGpPWpGaD
Dapiprazole—ADRA1A—Amine ligand-binding receptors—ADRB1—periodontitis	0.0246	0.0246	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Other—CXCR2—periodontitis	0.0227	0.0227	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0131	0.0131	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.0119	0.0119	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0109	0.0109	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCL3—periodontitis	0.01	0.01	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00988	0.00988	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00985	0.00985	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00968	0.00968	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—MMP2—periodontitis	0.00912	0.00912	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00875	0.00875	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00846	0.00846	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCL3—periodontitis	0.0083	0.0083	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.0082	0.0082	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00768	0.00768	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00765	0.00765	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—CXCL8—periodontitis	0.00757	0.00757	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCL3—periodontitis	0.00737	0.00737	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00728	0.00728	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00702	0.00702	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—MMP9—periodontitis	0.00685	0.00685	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00673	0.00673	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00658	0.00658	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00655	0.00655	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCR2—periodontitis	0.00644	0.00644	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00637	0.00637	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00635	0.00635	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00624	0.00624	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00566	0.00566	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCL3—periodontitis	0.00565	0.00565	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00564	0.00564	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00559	0.00559	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00546	0.00546	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00544	0.00544	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCR2—periodontitis	0.00535	0.00535	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCL3—periodontitis	0.00513	0.00513	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CCR2—periodontitis	0.00501	0.00501	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—ADRB1—periodontitis	0.00499	0.00499	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00496	0.00496	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00485	0.00485	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00483	0.00483	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCR2—periodontitis	0.00475	0.00475	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCL3—periodontitis	0.00469	0.00469	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCL3—periodontitis	0.00426	0.00426	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCL3—periodontitis	0.00417	0.00417	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CCR2—periodontitis	0.00416	0.00416	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—ADRB1—periodontitis	0.00414	0.00414	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—VIP—periodontitis	0.00409	0.00409	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCL3—periodontitis	0.00378	0.00378	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—VIP—periodontitis	0.00371	0.00371	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CCR2—periodontitis	0.00369	0.00369	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—ADRB1—periodontitis	0.00368	0.00368	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCR2—periodontitis	0.00364	0.00364	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—VIP—periodontitis	0.00339	0.00339	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCR2—periodontitis	0.00331	0.00331	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00324	0.00324	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—VIP—periodontitis	0.00308	0.00308	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCL3—periodontitis	0.00303	0.00303	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCR2—periodontitis	0.00302	0.00302	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—VIP—periodontitis	0.00301	0.00301	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CCR2—periodontitis	0.00283	0.00283	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—ADRB1—periodontitis	0.00282	0.00282	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCR2—periodontitis	0.00274	0.00274	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—VIP—periodontitis	0.00273	0.00273	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00269	0.00269	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCR2—periodontitis	0.00268	0.00268	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CCR2—periodontitis	0.00257	0.00257	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00256	0.00256	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—ADRB1—periodontitis	0.00256	0.00256	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCL3—periodontitis	0.00252	0.00252	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CCL2—periodontitis	0.00247	0.00247	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCR2—periodontitis	0.00244	0.00244	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00239	0.00239	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CCR2—periodontitis	0.00235	0.00235	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—ADRB1—periodontitis	0.00234	0.00234	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL3—periodontitis	0.00223	0.00223	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—VIP—periodontitis	0.00219	0.00219	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCR2—periodontitis	0.00213	0.00213	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00213	0.00213	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—ADRB1—periodontitis	0.00212	0.00212	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CCR2—periodontitis	0.00209	0.00209	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—ADRB1—periodontitis	0.00208	0.00208	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CCL2—periodontitis	0.00205	0.00205	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCR2—periodontitis	0.00195	0.00195	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCL8—periodontitis	0.00195	0.00195	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—MMP3—periodontitis	0.00195	0.00195	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00194	0.00194	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCR2—periodontitis	0.0019	0.0019	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00189	0.00189	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—ADRB1—periodontitis	0.00189	0.00189	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CCL2—periodontitis	0.00182	0.00182	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—VIP—periodontitis	0.00182	0.00182	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCR2—periodontitis	0.00162	0.00162	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCL8—periodontitis	0.00162	0.00162	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—MMP3—periodontitis	0.00162	0.00162	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—VIP—periodontitis	0.00162	0.00162	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00161	0.00161	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCR2—periodontitis	0.00152	0.00152	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ADRB1—periodontitis	0.00151	0.00151	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCR2—periodontitis	0.00144	0.00144	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCL8—periodontitis	0.00144	0.00144	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—MMP3—periodontitis	0.00144	0.00144	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00143	0.00143	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CCL2—periodontitis	0.00127	0.00127	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCR2—periodontitis	0.00126	0.00126	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ADRB1—periodontitis	0.00126	0.00126	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NTRK1—periodontitis	0.00124	0.00124	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP3—periodontitis	0.00115	0.00115	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCR2—periodontitis	0.00112	0.00112	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADRB1—periodontitis	0.00111	0.00111	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCL8—periodontitis	0.0011	0.0011	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCL2—periodontitis	0.00105	0.00105	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NTRK1—periodontitis	0.00103	0.00103	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCL8—periodontitis	0.001	0.001	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP3—periodontitis	0.000955	0.000955	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCL2—periodontitis	0.000934	0.000934	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCL8—periodontitis	0.000916	0.000916	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NTRK1—periodontitis	0.000913	0.000913	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP3—periodontitis	0.000849	0.000849	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCL8—periodontitis	0.000831	0.000831	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCL8—periodontitis	0.000813	0.000813	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL2—periodontitis	0.000748	0.000748	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCL8—periodontitis	0.000739	0.000739	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—FGF2—periodontitis	0.000676	0.000676	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL2—periodontitis	0.000621	0.000621	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCL8—periodontitis	0.000592	0.000592	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—IL6—periodontitis	0.000563	0.000563	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—FGF2—periodontitis	0.000561	0.000561	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL2—periodontitis	0.000552	0.000552	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP9—periodontitis	0.000535	0.000535	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—FGF2—periodontitis	0.000499	0.000499	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCL8—periodontitis	0.000491	0.000491	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6—periodontitis	0.000467	0.000467	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP9—periodontitis	0.000444	0.000444	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TGFB1—periodontitis	0.000441	0.000441	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL8—periodontitis	0.000436	0.000436	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6—periodontitis	0.000415	0.000415	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP9—periodontitis	0.000395	0.000395	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TGFB1—periodontitis	0.000366	0.000366	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6—periodontitis	0.000332	0.000332	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TGFB1—periodontitis	0.000325	0.000325	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6—periodontitis	0.000276	0.000276	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6—periodontitis	0.000245	0.000245	CbGpPWpGaD
